BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 19894659)

  • 1. Octreotide--additional conservative therapy for postoperative chylothorax in congenital heart disease.
    Paramés F; Freitas I; Fragata J; Trigo C; Pinto MF
    Rev Port Cardiol; 2009; 28(7-8):799-807. PubMed ID: 19894659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chylothorax in children after congenital heart surgery.
    Chan SY; Lau W; Wong WH; Cheng LC; Chau AK; Cheung YF
    Ann Thorac Surg; 2006 Nov; 82(5):1650-6. PubMed ID: 17062221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative chylothorax after cardiothoracic surgery in children.
    Chan EH; Russell JL; Williams WG; Van Arsdell GS; Coles JG; McCrindle BW
    Ann Thorac Surg; 2005 Nov; 80(5):1864-70. PubMed ID: 16242470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of chylothorax with octreotide after congenital heart surgery.
    Tatar T; Kilic D; Ozkan M; Hatipoglu A; Aslamaci S
    Thorac Cardiovasc Surg; 2011 Aug; 59(5):298-301. PubMed ID: 21394709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of octreotide acetate on intractable chylothorax after surgery for congenital heart diseases].
    Kaneko M; Hiramatsu T; Nishimura Y; Iwahashi M; Komori S; Shibata M; Yuzaki M; Okamura Y; Suzuki H; Takeuchi T; Shibuta S
    Kyobu Geka; 2006 Jul; 59(7):561-4. PubMed ID: 16856532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children.
    Landvoigt MT; Mullett CJ
    Pediatr Crit Care Med; 2006 May; 7(3):245-8. PubMed ID: 16575348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology and management of chylothorax following pediatric heart surgery.
    Milonakis M; Chatzis AC; Giannopoulos NM; Contrafouris C; Bobos D; Kirvassilis GV; Sarris GE
    J Card Surg; 2009; 24(4):369-73. PubMed ID: 19583606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoracic duct ligation for persistent chylothorax after pediatric cardiothoracic surgery.
    Nath DS; Savla J; Khemani RG; Nussbaum DP; Greene CL; Wells WJ
    Ann Thorac Surg; 2009 Jul; 88(1):246-51; discussion 251-2. PubMed ID: 19559234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chylothorax after surgery for congenital heart disease.
    Zuluaga MT
    Curr Opin Pediatr; 2012 Jun; 24(3):291-4. PubMed ID: 22498675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Octreotide for conservative management of postoperative chylothorax in the neonate].
    Rocha G; Henriques Coelho T; Correia Pinto J; Guedes MB; Guimarães H
    Acta Med Port; 2007; 20(5):467-70. PubMed ID: 18282446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative chylothorax: differences between patients who received median sternotomy or lateral thoracotomy for congenital heart disease.
    Wu JM; Yao CT; Kan CD; Yeh CN; Yang YR; Wang JN
    J Card Surg; 2006; 21(3):249-53. PubMed ID: 16684052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can octreotide be the first line treatment for chylothorax?
    Leelahanon S; Petlek W; Sontimuang W; Pochanart P; Tepakorn V; Ruangpeg S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S741-5. PubMed ID: 14700175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin for postoperative chylothorax after surgery for children with congenital heart disease.
    Lim KA; Kim SH; Huh J; Kang IS; Lee HJ; Jun TG; Park PW
    J Korean Med Sci; 2005 Dec; 20(6):947-51. PubMed ID: 16361802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide therapy in two children with intractable postoperative chylothorax.
    Hung WP; Wang JN; Chang HK; Wu JM
    Int J Cardiol; 2011 Feb; 146(3):e63-5. PubMed ID: 19193452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database.
    Mery CM; Moffett BS; Khan MS; Zhang W; Guzmán-Pruneda FA; Fraser CD; Cabrera AG
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):678-86.e1; discussion 685-6. PubMed ID: 24246545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of octreotide to treat congenital chylothorax.
    Paget-Brown A; Kattwinkel J; Rodgers BM; Michalsky MP
    J Pediatr Surg; 2006 Apr; 41(4):845-7. PubMed ID: 16567206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with single ventricle anatomy may respond better to octreotide therapy for chylothorax after congenital heart surgery.
    White SC; Seckeler MD; McCulloch MA; Buck ML; Hoke TR; Haizlip JA
    J Card Surg; 2014 Mar; 29(2):259-64. PubMed ID: 24354723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of newborn lymphangiectasia and chylothorax after cardiac surgery with octreotide infusion.
    Tibballs J; Soto R; Bharucha T
    Ann Thorac Surg; 2004 Jun; 77(6):2213-5. PubMed ID: 15172310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide and low-fat breast milk in postoperative chylothorax.
    Hamdan MA; Gaeta ML
    Ann Thorac Surg; 2004 Jun; 77(6):2215-7. PubMed ID: 15172311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide use in post-cardiac surgery chylothorax: a 12-year perspective.
    Aljazairi AS; Bhuiyan TA; Alwadai AH; Almehizia RA
    Asian Cardiovasc Thorac Ann; 2017 Jan; 25(1):6-12. PubMed ID: 27920229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.